By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Angiotensin II receptor antagonists (AT1 subtype) in combinations

Pharmaceutical group preparations

Substance Drugs
Aliskiren+Valsartan
Amlodipine+Irbesartan
Amlodipine+Losartane | | | |
Amlodipine+Losartane+Rosuvastatin
Amlodipine+Telmisartan | | | |
Amlodipine+Valsartan | | | | | | | | | | | |
Amlodipine+Valsartan+Hydrochlorothiazide | |
Azilsartan medoxomil+Chlortalidone
Hydrochlorothiazide+Candesartan | | |
Hydrochlorothiazide+Eprosartan
Hydrochlorothiazide+Irbesartan |
Hydrochlorothiazide+Losartan | | | | | | | | | | | | | | | |
Hydrochlorothiazide+Olmesartan medoxomil
Hydrochlorothiazide+Telmisartan | | | | | | |
Losartan+Hydrochlorothiazide |
Valsartan+Hydrochlorothiazide | | | | | | |
The active substance is not described | | |

Tree of pharmacological groups

Description

There is no detailed description, see related
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.